Skip to main content
. 2022 Nov 3;23(21):13436. doi: 10.3390/ijms232113436

Table 1.

Assessment of ability to inhibit lipid accumulation on HepG2 cells of candidate strains.

Samples Lipid Accumulation
(% of Control)
Percent Reduction
(Compared with OA-C)
Control 100 ± 1.12 -
OA-C 173.76 ± 7.18 #### -
Simvastatin (1 µM) 136.87 ± 5.23 ** 21.23
Lactobacillus gasseri MJM61024 122.59 ± 0.85 *** 29.45
Lactobacillus rhamnosus GG 151.53 ± 2.12 ** 12.79
Lactobacillus rhamnosus MJM60370 157.33 ± 5.47 * 8.93
Lactobacillus brevis MJM60386 132.25 ± 1.23 ** 23.89
Lactobacillus heveticus MJM60419 158.27 ± 4.87 * 8.91
Lactobacillus fermentum MJM60430 172.69 ± 4.23 0.62
Lactobacillus casei MJM60432 177.36 ± 5.06 −2.07
Lactobacillus paracasei MJM60434 152.72 ± 5.97 * 12.11
Lactobacilus helveticus MJM60463 160.42 ± 4.37 7.68
Streptococus thermophilus MJM60636 171.11 ± 2.98 1.53
Lactobacillus sakei MJM60958 92.46 ± 1.16 **** 46.79
Lactobacillus rhamnosus MJM60711 146.26 ± 3.19 ** 15.83
Lactobacilus helveticus MJM60825 152.72 ± 5.97 * 12.11
Lactobacillus plantarum MJM61025 145.53 ± 3.08 ** 16.25
Lactobacillus curvatus MJM61026 139.46 ± 3.39 ** 19.74

OA-C: 1 nM oleic acid and 7.5 µg/mL cholesterol (negative control). #### p < 0.0001 compared with control; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 compared with OA-C.